Jia-rui Zhou

Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study

Zhijie Wei, M. Xiong, Jian-ping Zhang, 2020, Annals of Hematology.

Sustained remission after ruxolitinib and chimeric antigen receptor T‐cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome‐like B‐cell precursor acute lymphoblastic leukemia with novel NPHP3‐JAK2 fusion

P. Cao, Xue Chen, Yang Zhang, 2021, Genes, chromosomes & cancer.

Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts

Zhijie Wei, M. Xiong, Jian-ping Zhang, 2021, Hematology.

Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.

Zhijie Wei, M. Xiong, Jian-ping Zhang, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study

Zhijie Wei, M. Xiong, Jian-ping Zhang, 2022, Leukemia & lymphoma.

Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status

Zhijie Wei, M. Xiong, Jian-ping Zhang, 2020, Annals of Hematology.

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia

Zhijie Wei, P. Lu, Xian Zhang, 2021, Frontiers in Immunology.

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study

Zhijie Wei, P. Lu, Xian Zhang, 2023, Frontiers in Immunology.

[Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders].

Fan Yang, Peng Cai, Y. Liu, 2009, Zhongguo shi yan xue ye xue za zhi.

Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant

P. Lu, Xian Zhang, Jun-fang Yang, 2023, Frontiers in immunology.

亲缘单倍型和同胞相合造血干细胞移植治疗完全缓解期急性T淋巴细胞白血病疗效比较

W. Ma, Y. Zhao, Yue Lu, 2021, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.